|
ZFX expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.76369999949478E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.37930000052722E-07 |
| Normal-vs-Stage2 |
1.131960E-01 |
| Normal-vs-Stage3 |
1.241540E-02 |
| Normal-vs-Stage4 |
6.575500E-04 |
| Stage1-vs-Stage2 |
6.999500E-02 |
| Stage1-vs-Stage3 |
1.888000E-01 |
| Stage1-vs-Stage4 |
9.176000E-01 |
| Stage2-vs-Stage3 |
6.378800E-01 |
| Stage2-vs-Stage4 |
2.657200E-01 |
| Stage3-vs-Stage4 |
4.243800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.26699999994473E-07 |
| Normal-vs-AfricanAmerican |
2.021700E-04 |
| Normal-vs-Asian |
2.353700E-02 |
| Caucasian-vs-AfricanAmerican |
3.734000E-01 |
| Caucasian-vs-Asian |
8.445600E-01 |
| AfricanAmerican-vs-Asian |
9.092200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62847513252018E-12 |
| Normal-vs-Female |
7.458000E-01 |
| Male-vs-Female |
2.34970000123624E-08 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.719900E-03 |
| Normal-vs-Extreme_Weight |
9.34779997852075E-09 |
| Normal-vs-Obese |
3.382700E-04 |
| Normal-vs-Extreme_Obese |
7.80630000000171E-05 |
| Normal_Weight-vs-Extreme_Weight |
4.124500E-02 |
| Normal_Weight-vs-Obese |
6.568600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.021980E-01 |
| Extreme_Weight-vs-Obese |
3.750300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.595400E-01 |
| Obese-vs-Extreme_Obese |
1.431990E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.529250E-01 |
| Normal-vs-Age(41-60Yrs) |
1.422280E-04 |
| Normal-vs-Age(61-80Yrs) |
4.518500018591E-09 |
| Normal-vs-Age(81-100Yrs) |
1.76689999997759E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.343600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.582200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.599840E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.337540E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.039610E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.153000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.00699999952647E-08 |
| Normal-VS-Type2 PRCC |
2.11080000001029E-06 |
| Normal-VS-KIRP CIMP |
5.740000E-01 |
| Normal-VS-Unclassified PRCC |
5.344000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.391200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.497870E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.311600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.926200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.832100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.592400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.10840028663984E-10 |
| Normal-vs-N1 |
1.020420E-01 |
| Normal-vs-N2 |
2.674400E-02 |
| N0-vs-N1 |
3.040200E-02 |
| N0-vs-N2 |
6.594200E-01 |
| N1-vs-N2 |
4.859200E-01 |
|
|
